Trevor W Stone Selected Research

neogenin

1/2020	Dependence and Guidance Receptors-DCC and Neogenin-In Partial EMT and the Actions of Serine Proteases.
1/2019	Serine protease modulation of Dependence Receptors and EMT protein expression.
4/2018	Obesity and Cancer: Existing and New Hypotheses for a Causal Connection.
1/2017	Microbial carcinogenic toxins and dietary anti-cancer protectants.
10/2016	Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trevor W Stone Research Topics

Disease

10	Inflammation (Inflammations) 01/2020 - 04/2009
7	Rheumatoid Arthritis 01/2022 - 01/2003
7	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2013
6	Neoplasms (Cancer) 01/2022 - 10/2016
5	Huntington Disease (Huntington's Disease) 01/2020 - 07/2003
5	Infections 01/2017 - 04/2007
5	Necrosis 10/2011 - 09/2006
5	Hypoxia (Hypoxemia) 11/2008 - 04/2003
4	Arthritis (Polyarthritis) 11/2021 - 10/2007
4	Alzheimer Disease (Alzheimer's Disease) 08/2021 - 04/2003
4	Schizophrenia (Dementia Praecox) 01/2021 - 06/2012
4	Osteoporosis 01/2020 - 01/2003
4	Stroke (Strokes) 01/2010 - 01/2002
3	Carcinogenesis 01/2022 - 02/2013
3	Cognitive Dysfunction 08/2021 - 10/2012
3	Central Nervous System Diseases (CNS Diseases) 08/2021 - 07/2003
3	Cerebral Malaria 01/2020 - 01/2003
3	Brain Diseases (Brain Disorder) 01/2017 - 07/2003
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2013 - 04/2007
2	Experimental Arthritis 01/2022 - 01/2021
2	Dementia (Dementias) 01/2021 - 04/2003
2	Wounds and Injuries (Trauma) 01/2019 - 11/2008
2	Adenocarcinoma 01/2019 - 10/2016
2	Obesity 04/2018 - 01/2017
2	Neuroblastoma 01/2017 - 10/2016
2	African Trypanosomiasis (Nagana) 01/2017 - 05/2009
2	Nervous System Diseases (Neurological Disorders) 01/2017 - 04/2003
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2011 - 04/2010
2	Ischemia 03/2005 - 04/2003
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2003 - 09/2002
1	Immune System Diseases (Immune Disorders) 01/2022
1	Osteoarthritis 01/2022
1	Ankylosing Spondylitis 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Trypanosomiasis 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Cerebellar Diseases (Cerebellar Syndrome) 08/2014

Drug/Important Bio-Agent (IBA)

17	KynurenineIBA 01/2022 - 09/2002
7	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 07/2003
7	Glutamic Acid (Glutamate)FDA Link 01/2017 - 04/2003
7	Adenosine (Adenocard)FDA LinkGeneric 10/2012 - 10/2003
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2014
5	Serine Proteases (Serine Protease)IBA 01/2022 - 10/2016
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2003
5	neogeninIBA 01/2020 - 10/2016
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 01/2002
4	SubtilisinIBA 01/2022 - 10/2016
4	anthranilic acid (anthranilate)IBA 01/2020 - 11/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012 - 03/2005
4	NeopterinIBA 10/2011 - 09/2002
4	Glutamate Receptors (Glutamate Receptor)IBA 02/2006 - 09/2002
3	CytokinesIBA 01/2022 - 11/2006
3	EnzymesIBA 01/2022 - 10/2013
3	Chymotrypsin FDA Link 01/2019 - 10/2016
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022 - 04/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	AcidsIBA 01/2020 - 01/2020
2	AntigensIBA 01/2020 - 01/2010
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2018 - 02/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 10/2016
2	Quinolinic AcidIBA 01/2017 - 04/2007
2	3-Hydroxyanthranilic AcidIBA 01/2010 - 11/2006
2	Kynurenic Acid (Kynurenate)IBA 06/2008 - 01/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 11/2006
2	purineIBA 01/2003 - 09/2002
2	PurinesIBA 01/2003 - 09/2002
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	invariant chain (Ii-Key)IBA 01/2022
1	carfilzomibIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2021
1	Decitabine FDA Link 11/2021
1	Memantine (Namenda)FDA Link 08/2021
1	Cholinergic Agents (Cholinergics)IBA 08/2021
1	N-Methylaspartate (NMDA)IBA 08/2021
1	Galantamine (Galanthamine)FDA LinkGeneric 08/2021
1	Vitamin B Complex (B Vitamins)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	SteroidsIBA 01/2020
1	CateninsIBA 01/2019
1	VimentinIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	NAD (NADH)IBA 01/2017
1	AntibodiesIBA 11/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2016
1	5-HT2C Serotonin ReceptorIBA 10/2013
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	XenobioticsIBA 02/2013
1	BicucullineIBA 09/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2007
1	Transcranial Direct Current Stimulation 01/2018